Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇹🇷TR · Science#643K to 10K
- 🇷🇴RO · Science#113500 to 3K
- 🇳🇿NZ · Science#165500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.2K to 4.8K🎙 Daily cadence·398 episodes·Last published today - Monthly Reach
Unique listeners across all episodes (30 days)
4K to 16K🇹🇷63%🇷🇴19%🇳🇿19% - Active Followers
Loyal subscribers who consistently listen
1.6K to 6.4K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHosts
Recent guests
Recent episodes
Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Jun 12, 2026
Unknown duration
HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy
Jun 11, 2026
Unknown duration
Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Jun 8, 2026
Unknown duration
Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Jun 5, 2026
Unknown duration
Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
Jun 3, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/12/26 | Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting | Dr Thomas Hutson from the Sarah Cannon Research Institute in Abilene, Texas, Dr Eric A Singer from The Ohio State University Comprehensive Cancer Center in Columbus and Dr Ulka Vaishampayan from the University of Michigan Health Rogel Cancer Center in Ann Arbor discuss recent data surrounding the management of localized renal cell carcinoma and share their perspectives on the clinical application.CME information and select publications | — | ||||||
| 6/11/26 | HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy | Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Virginia Kaklamani from the UT Health San Antonio MD Anderson Cancer Center in San Antonio, Texas, discuss patient cases and review relevant data on the management of ER-positive, HER2-negative metastatic breast cancer.CME information and select publications | — | ||||||
| 6/8/26 | Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances | Dr Christine L Hann from the Johns Hopkins University School of Medicine in Baltimore, Maryland, and Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the management of SCLC.CME information and select publications | — | ||||||
| 6/5/26 | Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays | Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer.CME information and select publications | — | ||||||
| 6/3/26 | Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer | Prof Ramez N Eskander from UC San Diego Moores Cancer Center in California, Dr Bradley J Monk from Florida Cancer Specialists & Research Institute in West Palm Beach and Dr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, review the treatment landscape of antibody-drug conjugate–directed therapy for gynecologic cancers and review recently presented clinical findings from the SGO 2026 Annual Meeting on Women’s Cancer.CME information and select publications | — | ||||||
| 6/2/26 | Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper | Prof Bernd Kasper from the Mannheim Cancer Center in Mannheim, Germany, discusses recent updates on available and novel treatment strategies for desmoid tumors. CME information and select publications here. | — | ||||||
| 5/28/26 | Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances | Dr Arvind Dasari from the University of Texas MD Anderson Cancer Center in Houston and Dr Anwaar Saeed from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania, discuss key clinical trial data regarding the management of colorectal cancer.CME information and select publications here. | — | ||||||
| 5/26/26 | Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays | Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer. CME information and select publications here. | — | ||||||
| 5/23/26 | Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances | Dr Jennifer R Brown and Prof Wojciech Jurczak discuss the selection and sequencing of Bruton tyrosine kinase-targeted therapy for patients with chronic lymphocytic leukemia and summarize major advances in the treatment landscape over the past year. CME information and select publications here. | — | ||||||
| 5/21/26 | Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer | Prof Nicoletta Colombo from the European Institute of Oncology IRCCS in Milan, Italy, Dr Alexander Olawaiye from the University of Pittsburgh School of Medicine in Pennsylvania, Dr Gottfried Konecny from the University of California, Los Angeles and Dr Shannon Westin from the MD Anderson Cancer Center in Houston, Texas, discuss key clinical trial data surrounding the management of ovarian cancer, alongside clinical cases and questions.CME information and select publications here. | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/20/26 | Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium | Dr Jaffer A Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and moderator Dr Samuel J Klempner from Massachusetts General Hospital in Boston review data supporting immunotherapy for gastroesophageal cancers and findings presented at the 2026 ASCO Gastrointestinal Cancers Symposium. CME information and select publications here. | — | ||||||
| 5/15/26 | PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida | Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer. CME information and select publications here. | — | ||||||
| 5/14/26 | Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer | Dr Floor J Backes from The James Cancer Hospital and Solove Research Institute in Columbus, Ohio, Dr Matthew A Powell from the Washington University School of Medicine in St Louis, Missouri, and Dr Ritu Salani from the David Geffen School of Medicine at UCLA in Los Angeles, California, discuss key clinical trial data, clinical cases and questions surrounding the management of endometrial cancer using immunotherapy. CME information and select publications here. | — | ||||||
| 5/7/26 | Oncology Nursing Update: Nonmelanoma Skin Cancers — An Interview with Dr Nikhil Khushalani✨ | nonmelanoma skin cancerstreatment strategies+3 | Dr Nikhil I Khushalani | Moffitt Cancer Center | Tampa, Florida | nonmelanoma skin cancertreatment strategies+3 | — | 1h 03m 49s | |
| 5/3/26 | Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | localized colorectal cancerclinical findings+3 | Dr Stacey A CohenDr Jenny Seligmann+1 | Fred Hutchinson Cancer CenterUniversity of Leeds+1 | — | colorectal cancerASCO+3 | — | 18m 11s | |
| 4/30/26 | Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances✨ | breast cancerclinical trials+3 | Dr Aditya BardiaDr Erica Mayer | University of California Los AngelesDana-Farber Cancer Institute | Boston, Massachusetts | oral SERDsbreast cancer+3 | — | 57m 18s | |
| 4/27/26 | EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances✨ | EGFR mutationnon-small cell lung cancer+3 | Dr Suresh S RamalingamDr Helena Yu | EGFRNon-Small Cell Lung Cancer | — | EGFR mutationnon-small cell lung cancer+3 | — | 57m 26s | |
| 4/24/26 | Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | immunotherapytargeted therapy+3 | Dr Jaffer AjaniDr Samuel Klempner+2 | The University of Texas MD Anderson Cancer CenterMassachusetts General Hospital+2 | — | immunotherapytargeted therapy+4 | — | 16m 54s | |
| 4/23/26 | Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances✨ | prostate cancertherapy selection+3 | Dr Andrew J ArmstrongDr Scott T Tagawa | Duke Cancer InstituteWeill Cornell Medicine Meyer Cancer Center | Durham, North CarolinaNew York, New York | prostate cancertherapy sequencing+3 | — | 58m 21s | |
| 4/20/26 | Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances✨ | Acute Myeloid Leukemiaclinical trials+3 | Dr Amir FathiDr Eunice S Wang | Massachusetts General HospitalRoswell Park Comprehensive Cancer Center | Boston, MassachusettsBuffalo, New York | Acute Myeloid Leukemiamenin inhibitors+3 | — | 58m 54s | |
| 4/17/26 | Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays✨ | lung cancercirculating tumor DNA+3 | Dr Natalie Vokes | The University of Texas MD Anderson Cancer CenterOncology Today | — | lung cancercirculating tumor DNA+3 | — | 27m 12s | |
| 4/16/26 | HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making✨ | HR-positive metastatic breast cancerbiomarker assessment+3 | Dr Seth Wander | Massachusetts General Hospital | — | HR-positivemetastatic breast cancer+4 | — | 1h 00m 13s | |
| 4/15/26 | Metastatic Bladder Cancer — Rapid Case Review Issue 4✨ | metastatic bladder cancerurothelial cancer+3 | Dr Matthew Milowsky | UNC Lineberger Comprehensive Cancer CenterEmory University School of Medicine+1 | — | metastatic bladder cancerurothelial cancer+3 | — | 27m 45s | |
| 4/14/26 | ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy✨ | metastatic breast cancerfirst-line therapy+3 | Dr Virginia F BorgesDr Ian E Krop | University of Colorado Anschutz Medical CampusYale Cancer Center | — | ER-positiveHER2-positive+5 | — | 57m 59s | |
| 4/13/26 | Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | localized colorectal cancerclinical findings+3 | Dr Stacey A CohenDr Jenny Seligmann+1 | Fred Hutchinson Cancer CenterUniversity of Leeds+1 | — | colorectal cancerASCO+4 | — | 15m 06s | |
Showing 25 of 418
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
3 placements across 3 markets.
Chart Positions
3 placements across 3 markets.